Stock exchanges & markets

Overview Watchlists

Addex regains global rights to GABAB PAM assets from Indivior

25. Sep 2026

(AWP Alliance News) - Addex Therapeutics regained full global rights to its GABAB positive allosteric modulator portfolio from Indivior on Sept. 25, 2026. The move returns ownership of a development candidate Indivior selected for substance use disorders. Addex can now pursue additional indications beyond the original collaboration scope.

The company said it will weigh options including seeking new partners or advancing the programs further before partnering.

https://www.globenewswire.com/NewsRoom/ReleaseNg/402517577

Disclaimer: This news brief was created using generative artificial intelligence. Addex Therapeutics Ltd. published the original content used to generate this news brief via GlobeNewswire on September 25, 2026, and is solely responsible for the information contained therein.

Learn more about our offers

  • Keep a close eye on your favourite shares

    Watchlist

    Don’t miss out on share price trends. Track your favourite shares (CH, EU & US) in real time with customised watchlists.

    Sign up now

  • Compare ETFs systematically

    ETF Compass

    Find the products that suit your investment goals.

    Try the ETF Compass

  • How to find the best shares

    theScreener

    Search through around 6,500 securities using criteria such as opportunities and risks or expected dividend yield.

    Test now